Amylin

Amylin Ignites the Biotech Sector
Motley Fool
Sat, 03/31/12 - 11:56 am
Amylin
Amilyn Soars on News of Spurned Bristol-Myers Bid
Barron's
Wed, 03/28/12 - 10:27 am
Amylin
Bristol-Myers Squibb
M&A
Bristol-Myers offers $3.5 billion for Amylin-Bloomberg
Reuters
Wed, 03/28/12 - 10:12 am
Amylin
Bristol-Myers Squibb
M&A
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Achillion
Amylin
Ariad Pharmaceuticals
Aveo Pharmaceutical
Cell Therapeutics
EXACT Sciences
Idenix
Exelixis
Halozyme
Lexicon Pharmaceuticals
Nektar
Momenta
ONYX Pharmaceuticals
Optimer Pharmaceuticals
PDL Biopharma
Questcor Pharmaceuticals
Santarus
Spectrum Pharmaceuticals
Regeneron
Vivus
Lilly, Amylin receive European approval for expanded use of diabetes treatment Byetta
Yahoo/AP
Fri, 03/23/12 - 11:27 am
Eli Lilly
Amylin
Europe
diabetes
Byetta
Amylin Pharmaceuticals Pulling Ahead Of Roche In Anti-Obesity Drugs?
Seeking Alpha
Mon, 03/19/12 - 10:47 am
Roche
obesity
Amylin
diabetes
Xenical
Orlistat
metreleptin
Alli
After Gilead's Drop: Hedging 5 Biotechnology Stocks
Seeking Alpha
Mon, 02/20/12 - 01:44 pm
Gilead
Acorda
Amylin
Celgene
United Therapeutics
EU suggests new approval for diabetes drug Byetta
Yahoo/AP
Fri, 02/17/12 - 01:14 pm
Europe
diabetes
Byetta
Amylin
Eli Lilly
FDA nod fuels Bydureon vs. Victoza bout
Fierce Pharma
Mon, 01/30/12 - 04:00 pm
Victoza
diabetes
Bydureon
FDA
Amylin
Novo Nordisk
Alkermes
Amylin Gets Its Yes; Now For The Hard Work
Seeking Alpha
Sat, 01/28/12 - 12:36 pm
Amylin
Bydureon
diabetes
Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try
Bloomberg
Fri, 01/27/12 - 03:12 pm
Amylin
FDA
Alkermes
diabetes
Bydureon
FDA Pending Catalysts For 5 Biotechs
Seeking Alpha
Wed, 01/25/12 - 10:51 am
FDA
Amylin
NeurogesX
Threshold Pharmaceuticals
Astex
Cell Therapeutics
2 Pharmaceutical Stocks Ready To Move
Seeking Alpha
Mon, 01/23/12 - 09:52 am
Amylin
Prolor
The New Amylin - More Risk, More Potential
Seeking Alpha
Tue, 01/10/12 - 09:05 am
Amylin
Bydureon
diabetes
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
The top 10 biotech deal terminations of 2011
Fierce Biotech
Thu, 12/22/11 - 08:00 am
GSK
Targacept
Shire
Renovo
Merck
Addex
Diamyd Medical
JNJ
Janssen Pharmaceuticals
Novartis
PeptImmune
Solvay
Depomed
Eli Lilly
Amylin
Portola Pharmaceuticals
Paratek
Cephalon
ImmuPharma
Diabetes Meds, Pancreatitis & Prescribing Habits
Pharmalot
Fri, 12/9/11 - 11:26 am
diabetes
pancreatitis
physicians
Byetta
Amylin
Januvia
Merck
A Trading Strategy For 7 Biotech/Healthcare Stocks With Upcoming PDUFA Date
Seeking Alpha
Tue, 12/6/11 - 09:21 am
Alkermes
Amylin
Antares
AstraZeneca
Bristol-Myers Squibb
Merck
Eli Lilly
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Amylin's Agreement with Lilly Will Not Lead It To Profitablity
Seeking Alpha
Mon, 11/21/11 - 06:29 pm
Eli Lilly
Amylin
GSK
Merck
Alkermes
Byetta
Novo Nordisk

Pages